An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells

Leukemia stem cells (LSCs) are thought to play a central role in the pathogenesis of acute leukemia and likely contribute to both disease initiation and relapse. Therefore, identification of agents that target LSCs is an important consideration for the development of new therapies. To this end, we h...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Guzman, Monica L., Rossi, Randall M., Neelakantan, Sundar, Li, Xiaojie, Corbett, Cheryl A., Hassane, Duane C., Becker, Michael W., Bennett, John M., Sullivan, Edmund, Lachowicz, Joshua L., Vaughan, Andrew, Sweeney, Christopher J., Matthews, William, Carroll, Martin, Liesveld, Jane L., Crooks, Peter A., Jordan, Craig T.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2007
Matèries:
Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2234793/
https://ncbi.nlm.nih.gov/pubmed/17804695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-05-090621
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars